Boyanov & Co.
More informationBoyanov & Co. is well regarded in the healthcare and life sciences space for its stellar client roster of pharmaceutical manufacturers, generics companies and pharmacies. The firm has extensive experience relating to Bulgarian and EU regulations in the pharma sector and is therefore well placed to advise on a broad range of market access issues, intellectual property protection and trade mark registration, patent litigation and commercial disputes regarding the sale of medicines and pharmaceutical price regulation matters. Dispute resolution expert Kina Chuturkova represents pharmaceutical clients in litigation and international arbitration proceedings, while Peter Petrov uses his regulatory and EU law expertise when advising landmark clients such as Pfizer, Merck and AbbVie on an ongoing basis. Nedyalka Novakova further strengthens the team's offering.
Key clients
- Neola Pharma EOOD
- F. Hoffmann La Roche
- AbbVie
- ARPharM Bulgaria
- Bayer
- Novartis
- GSK
- Celgene Corporation
- Merck
- Medtronic
- Pfizer Bulgaria
- Anika Therapeutics
- AstraZeneca
- Baxter Health
- Stada
- ICON Plc
- Ferring Pharmaceuticals
- Grünenthal
- Allergan, Inc.
- Roche Bulgaria
- Sandoz
- Pharmapro
- Syneos Health
- Sofmedica
- Arcadia Consumer Healthcare
- Ottobock
- MagnaPharm
Work highlights
- Representing a global innovative pharmaceutical manufacturer in its challenge against Bulgarian legislation.
- Supported the Bulgarian pharmaceutical industry association ARPharM in its advocacy efforts to ensure a sustainable supply of therapies to Bulgarian patients in the context of various legislative initiatives.
- Continuing to regularly advise a significant portfolio of global pharmaceutical leaders, including AbbVie, AstraZeneca, Bayer, GSK, Merck, Novartis, Pfizer, Sandoz, Roche and others, on various aspects of their presence in the Bulgarian pharmaceutical market.
Lawyers
Practice head
The lawyer(s) leading their teams.
Kina Chuturkova, Peter Petrov